Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
AIDS (London, England)|May 1, 1996
Virological and immunological analysis of a triple combination pilot study with loviride, lamivudine and zidovudine in HIV-1-infected patientsS Staszewski, V Miller, S Rehmet, et al.
JAMA|March 20, 2001
Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trialS Staszewski, P Keiser, J Montaner, et al.
European Journal of Medical Research|May 11, 2010
The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive IndividualsM Vogel, G Ahlenstiel, B Hintsche, et al.
The Journal of Clinical Investigation|March 23, 2000
Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNAG P Rizzardi, R J De Boer, S Hoover, et al.
Antimicrobial Agents and Chemotherapy|April 4, 1998
A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugsK Hertogs, M P de Béthune, V Miller, et al.
Lancet (London, England)|September 6, 2003
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studiesG Chêne, J A C Sterne, M May, et al.
International Journal of Antimicrobial Agents|March 13, 1999
Efficacy and safety of combination therapy with delavirdine and zidovudine: a European/Australian phase II trialA M Been-Tiktak, C A Boucher, F Brun-Vezinet, et al.
Antiviral Therapy|January 18, 2005
Updated European recommendations for the clinical use of HIV drug resistance testingA M Vandamme, A Sönnerborg, M Ait-Khaled, et al.
Pageof 17